149 related articles for article (PubMed ID: 33865224)
1. Exploring the changes of brain immune microenvironment in Alzheimer's disease based on PANDA algorithm combined with blood brain barrier injury-related genes.
Lu S; Kong W; Wang S
Biochem Biophys Res Commun; 2021 Jun; 557():159-165. PubMed ID: 33865224
[TBL] [Abstract][Full Text] [Related]
2. TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer's microenvironment.
Liu Q; Zhu L; Liu X; Zheng J; Liu Y; Ruan X; Cao S; Cai H; Li Z; Xue Y
RNA Biol; 2020 Sep; 17(9):1293-1308. PubMed ID: 32372707
[TBL] [Abstract][Full Text] [Related]
3. The role of LINC00094/miR-224-5p (miR-497-5p)/Endophilin-1 axis in Memantine mediated protective effects on blood-brain barrier in AD microenvironment.
Zhu L; Lin M; Ma J; Liu W; Gao L; Wei S; Xue Y; Shang X
J Cell Mol Med; 2019 May; 23(5):3280-3292. PubMed ID: 30801976
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients Control CCL4 and CXCL10 Levels in a Human Blood Brain Barrier Model.
Verite J; Janet T; Julian A; Chassaing D; Page G; Paccalin M
Curr Alzheimer Res; 2017; 14(11):1215-1228. PubMed ID: 28413983
[TBL] [Abstract][Full Text] [Related]
6. High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice.
Thériault P; ElAli A; Rivest S
Oncotarget; 2016 Oct; 7(42):67808-67827. PubMed ID: 27661129
[TBL] [Abstract][Full Text] [Related]
7. Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
Kong W; Mou X; Deng J; Di B; Zhong R; Wang S; Yang Y; Zeng W
PLoS One; 2017; 12(7):e0180337. PubMed ID: 28719625
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.
Han ZJ; Xue WW; Tao L; Zhu F
CNS Neurosci Ther; 2018 Dec; 24(12):1253-1263. PubMed ID: 30106219
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
Kamat PK; Kyles P; Kalani A; Tyagi N
Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.
Sardi F; Fassina L; Venturini L; Inguscio M; Guerriero F; Rolfo E; Ricevuti G
Autoimmun Rev; 2011 Dec; 11(2):149-53. PubMed ID: 21996556
[TBL] [Abstract][Full Text] [Related]
11. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease.
Zhang Z; Gan Q; Han J; Tao Q; Qiu WQ; Madri JA
J Cereb Blood Flow Metab; 2023 Jul; 43(7):1027-1041. PubMed ID: 37051650
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
[TBL] [Abstract][Full Text] [Related]
13. Construction of Transcriptional Regulatory Network of Alzheimer's Disease Based on PANDA Algorithm.
Ding J; Kong W; Mou X; Wang S
Interdiscip Sci; 2019 Jun; 11(2):226-236. PubMed ID: 29675796
[TBL] [Abstract][Full Text] [Related]
14. [Role of the blood-brain barrier in Alzheimer's disease].
Gosselet F; Candela P; Cecchelli R; Fenart L
Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
[TBL] [Abstract][Full Text] [Related]
15. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients.
Liu ZP; Wang Y; Zhang XS; Xia W; Chen L
Mol Biosyst; 2011 May; 7(5):1441-52. PubMed ID: 21336338
[TBL] [Abstract][Full Text] [Related]
16. Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
Kouki MA; Pritchard AB; Alder JE; Crean S
J Alzheimers Dis; 2022; 85(3):957-973. PubMed ID: 34897087
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
18. The effect of insomnia on development of Alzheimer's disease.
Sadeghmousavi S; Eskian M; Rahmani F; Rezaei N
J Neuroinflammation; 2020 Oct; 17(1):289. PubMed ID: 33023629
[TBL] [Abstract][Full Text] [Related]
19. Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.
Chang R; Al Maghribi A; Vanderpoel V; Vasilevko V; Cribbs DH; Boado R; Pardridge WM; Sumbria RK
Mol Pharm; 2018 Nov; 15(11):4963-4973. PubMed ID: 30252487
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 restores Aβ
Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
